IHSM

View Original

Standard Process | ProSynbiotic

Jameel Moksa Battle

ProSynbiotic is a daily probiotic & prebiotic blend for gut health. It is a probiotic for everyday microbial support, a synergistic blend of four probiotic microbes, and a prebiotic fiber designed to support overall intestinal health.

Don't miss out on exclusive discounts and free shipping – they're just a few clicks away!

Primary Benefits

  • Contains inulin which is used by probiotic bacteria as food

  • Supports a healthy gut microbial environment*

  • Supports normal bowel regularity*

  • Supports the body's natural immune system response function*

Dietary Considerations

  • Vegetarian

  • Certified Organic

  • MOSA Certified Organic

Product Details

  • Contains research-supported strains of lactic acid bacteria (Lactobacillus and Bifidobacterium), and Saccharomyces cerevisiae var. boulardii

  • Contains inulin and galactooligosaccharide (nondigestible carbohydrates), both of which are used by probiotic bacteria as food

  • Useful in maintaining a healthy gut microbial environment

  • Helps support the body's natural absorption of calcium and magnesium

  • Improves nutrient digestion and absorption

  • Supports normal bowel regularity and consistency

  • Supports the body's natural immune system response function*

Suggested Use

  • Take three capsules per day, or as directed.

Warnings

  • If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use.  

  • Keep out of reach of Children.

References:

  1. Alzahrani, A., Alzahrani, A. J., & Shori, A. B. (2023). Inflammatory Bowel Disease: A focus on the Role of Probiotics in Ulcerative Colitis. Open Access Macedonian Journal of Medical Sciences, 11(F), Article F. https://doi.org/10.3889/oamjms.2023.11020

  2. Axelsson, L. (2004) Lactic Acid Bacteria Classification and Physiology. In Salminen, S., Wright, A.V. and Ouwehand, A., Eds., Lactic Acid Bacteria Microbiological and Functional Aspects, 3rd Edition, Marcel Dekker, New York, 1-67. - References—Scientific Research Publishing. (n.d.). Retrieved November 3, 2024, from https://www.scirp.org/reference/ReferencesPapers?ReferenceID=1993823

  3. Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005). Host-bacterial mutualism in the human intestine. Science (New York, N.Y.), 307(5717), 1915–1920. https://doi.org/10.1126/science.1104816

  4. Bian, G., Gloor, G. B., Gong, A., Jia, C., Zhang, W., Hu, J., Zhang, H., Zhang, Y., Zhou, Z., Zhang, J., Burton, J. P., Reid, G., Xiao, Y., Zeng, Q., Yang, K., & Li, J. (2017). The Gut Microbiota of Healthy Aged Chinese Is Similar to That of the Healthy Young. mSphere, 2(5), e00327-17. https://doi.org/10.1128/mSphere.00327-17

  5. Bifidobacteria can protect from enteropathogenic infection through production of acetate. - Abstract—Europe PMC. (n.d.). Retrieved November 3, 2024, from https://europepmc.org/article/med/21270894

  6. Clinical Trials of Probiotic Strains in Selected Disease Entities—PubMed. (n.d.). Retrieved November 3, 2024, from https://pubmed.ncbi.nlm.nih.gov/32565816/

  7. Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by (1)H Nuclear Magnetic Resonance spectroscopy—PubMed. (n.d.). Retrieved November 3, 2024, from https://pubmed.ncbi.nlm.nih.gov/19446905/

  8. Effect of the probiotic strain Bifidobacterium animalis subsp. Lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: A randomised, double-blind, placebo-controlled, parallel-group trial—PubMed. (n.d.). Retrieved November 3, 2024, from https://pubmed.ncbi.nlm.nih.gov/26382580/

  9. Frontiers | Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. (n.d.). Retrieved November 3, 2024, from https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2015.01543/full

  10. Frontiers | Gut Bifidobacteria Populations in Human Health and Aging. (n.d.). Retrieved November 3, 2024, from https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2016.01204/full

  11. Garcia Vilela, E., De Lourdes De Abreu Ferrari, M., Oswaldo Da Gama Torres, H., Guerra Pinto, A., Carolina Carneiro Aguirre, A., Paiva Martins, F., Marcos Andrade Goulart, E., & Sales Da Cunha, A. (2008). Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn’s disease in remission. Scandinavian Journal of Gastroenterology, 43(7), 842–848. https://doi.org/10.1080/00365520801943354

  12. Health Benefits of Probiotics: A Review—PMC. (n.d.). Retrieved November 3, 2024, from https://pmc.ncbi.nlm.nih.gov/articles/PMC4045285/

  13. Inulin and oligofructose: What are they? - PubMed. (n.d.). Retrieved November 3, 2024, from https://pubmed.ncbi.nlm.nih.gov/10395607/

  14. Mechanisms of probiotic actions—A review | Request PDF. (n.d.). Retrieved November 3, 2024, from https://www.researchgate.net/publication/26840302_Mechanisms_of_probiotic_actions_-_A_review

  15. (PDF) Bifidobacteria can protect from enteropathogenic infection through production of acetate. (n.d.). Retrieved November 3, 2024, from https://www.researchgate.net/publication/49788847_Bifidobacteria_can_protect_from_enteropathogenic_infection_through_production_of_acetate

  16. Probiotics That Modify Disease Risk—ScienceDirect. (n.d.). Retrieved November 3, 2024, from https://www.sciencedirect.com/science/article/pii/S002231662210235X

  17. The Probiotic Bifidobacterium breve B632 Inhibited the Growth of Enterobacteriaceae within Colicky Infant Microbiota Cultures—PMC. (n.d.). Retrieved November 3, 2024, from https://pmc.ncbi.nlm.nih.gov/articles/PMC4163384/

    Walter, J. (2008). Ecological role of lactobacilli in the gastrointestinal tract: Implications for fundamental and biomedical research. Applied and Environmental Microbiology, 74(16), 4985–4996. https://doi.org/10.1128/AEM.00753-08